Call Toll-Free: (866) 699-EDGE - (212) 406-1600

Belviq, Belviq XR Lawsuit (Lorcaserin generic)

The U.S. Food and Drug Administration (FDA) requests that manufacturers voluntarily withdraw on February, 13th 2020. They are prescription weight-loss drugs. A release of a study on the drugs found a correlation between taking Belviq increased rates of cancer.

A user if you have cancer a Belviq, Belviq XR lawsuit can be undertaken to award damages for you, whether by jury verdict or settlement :

  1. Past and future medical expenses may be awarded related to cancer from taking Belviq, Belviq XR.
  2. If you have cancer believe it was caused by taking Belviq, Belviq XR, you may be able to recover the costs of treatment and recovery process Past and future pain and suffering (physical and mental).
  3. Have lost wages in the past or future due to cancer from taking Belviq, Belviq XR.
  4. Loss of earning capacity due to cancer past and future wages.
  5. Past and future loss of enjoyment of life.
  6. Punitive damages, if appropriate.
New York
Gurfein Douglas LLP — New York
11 Park Place, 7th Floor New York City, NY 10007
Phone: (212) 406-1600
Toll-Free (866) 699-EDGE
New Jersey
Gurfein Douglas LLP — New Jersey 175 Rock Road, Bldg. 2 Glen Rock, NJ 07452 Phone: (201) 477-0094 Toll-Free (866) 699-EDGE
All rights reserved © 2002-2021 Gurfein Douglas LLP
This website contains attorney advertising. Prior results do not guarantee a similar outcome.
PHILIPS RECALLS CPAC AND BiPAP MACHINES
This is default text for notification bar